Vidyya Medical News Service
*
Volume 5 Issue 210 Published - 14:00 UTC 08:00 EST 29-July-2003 Next Update - 14:00 UTC 08:00 EST 30-July-2003
little clear gif used for spacer
.
*

FDA approves Humatrope for short stature
The Food and Drug Administration (FDA) today approved a new indication for Humatrope (Somatropin, rDNA origin, for injection), a brand of growth hormone, for the long-term treatment of children with idiopathic (of unknown origin) short stature, also called non-growth hormone deficient short stature.  more

*
Prescribing information: Humatrope
Humatrope Prescribing Information is available for download in Portable Document Format (PDF). You will need Adobe's Acrobat Reader software to read the full prescribing information.  more

 


*
FDA approves enbrel to treat ankylosing spondylitis
FDA today approved an application for etanercept (trade-name Enbrel), a genetically engineered protein, for a new indication for treatment of patients with active ankylosing spondylitis (AS), a chronic inflammatory disease affecting primarily the lower back and joints.  more

*
Type 2 diabetes linked to a family of metabolic genes
An ambitious and exhaustive genetic study, led by investigators at the Joslin Diabetes Center and the Children's Hospital Boston Informatics Program, has pinpointed a group of genes that are involved in type 2 diabetes and shows that the activity of these genes changes even before overt diabetes develops. more

*
Common misperceptions of bipolar disorder may lead to misdiagnosis in children
Aiming to gain a better understanding of the public's perceptions of bipolar disorder (manic-depression), a recent survey revealed that only 11 percent of adults believe the illness can occur at any age and only 40 percent believe it is hereditary -- two common misperceptions that may lead to misdiagnosis in children.  more

 
little clear gif used for a space